Emerging leader in cannabis-infused beverages, BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) (“BevCanna” or the “Company”) announced today it has signed an agreement with Maritime-based licensed cannabis producer Argentia Gold Corp. (“Argentia”) to exclusively represent BevCanna’s line of cannabis-infused beverages in Newfoundland, PEI and New Brunswick. The two companies have entered a non-binding letter of intent (the “LOI”) for Argentia to distribute and sell BevCanna products across the three provinces, with the intent of signing a definitive agreement (the “Agreement”) within the next 45 days.

With consumption rates for cannabis among the highest in Canada (25.9 per cent for Newfoundland and 20.9 per cent for PEI), the Atlantic provinces represent an attractive market for cannabis-infused product producers like BevCanna. The market for cannabis is anticipated to expand to $56M annually in New Brunswick by 2025, $49M in Newfoundland and $21M per year in PEI. BevCanna chose Argentia Gold for their strong knowledge of the Atlantic cannabis markets and their sales strategy for the nearly 50 Licensed Retailers across the three provinces. Engaging an experienced partner in the region will also allow BevCanna to focus on other significant Canadian markets, while building exposure and revenue in the Atlantic provinces.


“Argentia is the ideal partner for us in the burgeoning Atlantic market,” said John Campbell, Chief Strategic Officer for BevCanna. “They have an unparalleled knowledge of the regional cannabis landscape and a detailed understanding of the distribution network. They also have excellent relationships with the provincial bodies in these provinces, which will assist us as we focus on building our presence in the region.”

“We’re excited to bring BevCanna’s innovative and diverse cannabis-infused beverage portfolio to the Atlantic region,” commented Dave Thomson, Head of Business Development for Argentia Gold. “We are laser focused on bringing the same high-quality, in-demand products that are being sold in the larger Canadian markets to the Atlantic provinces, and we expect BevCanna’s upcoming line of beverages to be extremely popular with consumers.”

Terms of the Agreement

  • BevCanna and Argentia intend to enter into an exclusive distribution agreement, to distribute and sell BevCanna products in the provinces of Newfoundland, PEI, and New Brunswick
  • BevCanna will provide finished cannabis and/or cannabis extract products
  • Argentia will provide supply chain, distribution, and sales infrastructure and services in the specified provinces
  • In consideration for such infrastructure and services provided by Argentia, Bevcanna will pay a service fee of 15 per cent, with up to an additional 5 per cent bonus to be paid based upon the achievement of mutually agreed sales milestones
  • Additional commercial terms will be outlined in the Agreement
  • Entry into the Agreement is subject to satisfactory completion of, among other things:
  • Due diligence investigations by each partner;
  • Negotiation of the Agreement; and
  • Approval by each partner’s board of directors.

About BevCanna Enterprises Inc.
BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) develops and manufactures cannabinoid-infused beverages and consumer products for in-house brands and white label clients. With decades of experience creating, branding and distributing iconic brands that resonate with consumers on a global scale, the team demonstrates an expertise unmatched in the emerging cannabis beverage category. Based in British Columbia, Canada, BevCanna has a 292-acre outdoor cultivation site in the fertile Okanagan Valley and the exclusive rights to a pristine spring water aquifer, as well as a world-class 40,000-square-foot, HACCP certified manufacturing facility, with a current bottling capacity of up to 210M bottles per annum.

About Argentia
Argentia Gold Corporation is a licensed producer in Newfoundland and Labrador. Its facility, a former U.S. naval base turned industrial park on the deep-water Port of Argentia, encompasses approximately 80,000 square feet on 10 acres of land.

Disclaimer for Forward-Looking Information
This news release contains forward-looking information that involves various risks and uncertainties regarding future events. Such forward-looking information can include without limitation statements based on current expectations involving a number of risks and uncertainties and are not guarantees of future performance of the Company. Forward-looking statements made in this news release relate to: the intention to enter into the Agreement, and the timing thereof; that the market for cannabis is anticipated to expand to $56M annually in New Brunswick by 2025, $49M in Newfoundland and $21M per year in PEI; that engaging an experienced partner in the region will also allow BevCanna to focus on other significant Canadian markets, while building exposure and revenue in the Atlantic provinces; the burgeoning Atlantic market; Argentia’s excellent relationships with the provincial bodies in these provinces will assist BevCanna as it focuses on building its presence in the region; the expectation that BevCanna’s upcoming line of beverages to be extremely popular with consumers; statements with respect to the Agreement and its contemplated terms, including that BevCanna will provide finished cannabis and/or cannabis extract products; Argentia will provide supply chain, distribution, and sales infrastructure and services in the specified provinces; and the consideration payable thereunder; and other matters relating to the Company’s business plans. There are numerous risks and uncertainties that could cause actual results and the Company’s plans and objectives to differ materially from those expressed in the forward-looking information, including the inability of the parties to enter into the Agreement; the inability of the Company to obtain necessary licences from Health Canada with respect to cannabis; and adverse market conditions. Actual results and future events could differ materially from those anticipated in such information. These and all subsequent written and oral forward-looking information are based on estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. The Company disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

Click here to connect with BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) for an Investor Presentation

Source

American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.

Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.

Keep reading... Show less

An Emerging Markets Sponsored Commentary

Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.

Keep reading... Show less

As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.

A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.

Keep reading... Show less

The product will include polyphenols known to have significant health benefits.

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).

Keep reading... Show less